PowdAir Plus Dry Powder Inhaler

H&T Presspart is pleased to announce our PowdAir Plus dry powder inhaler device has been nominated in the ‘Cost Effective’ category in the Innopack China 2021 awards.

The ‘Cost Effective’ Award is presented to a product or company that delivers economic excellence to a pharmaceutical company through reform or innovation.

H&T Presspart’s PowdAir Plus is a patented capsule-based dry powder inhaler, ideal for developing markets such as Asia-Pacific, because of its advanced simplicity, ease of use and affordability.

Most other DPIs have been designed for developed markets and incorporate multiple components and complex mechanics. In contrast, PowdAir Plus is a complete unit with no metal or separate parts. Neat and compact, its novel all-plastic, four-component design minimises manufacturing assembly and production costs, while improving the device’s resilience to frequent use.

The winners will be announced on December 13th. Good luck to all the finalists in the Awards!